GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Price-to-Owner-Earnings

Center Laboratories (ROCO:4123) Price-to-Owner-Earnings : 288.21 (As of May. 30, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Price-to-Owner-Earnings?

As of today (2025-05-30), Center Laboratories's share price is NT$40.35. Center Laboratories's Owner Earnings per Share (TTM) ended in Mar. 2025 was NT$0.14. It's Price-to-Owner-Earnings for today is 288.21.


The historical rank and industry rank for Center Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

ROCO:4123' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.59   Med: 15.11   Max: 275
Current: 275

During the past 13 years, the highest Price-to-Owner-Earnings of Center Laboratories was 275.00. The lowest was 5.59. And the median was 15.11.


ROCO:4123's Price-to-Owner-Earnings is ranked worse than
96.87% of 447 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs ROCO:4123: 275.00

As of today (2025-05-30), Center Laboratories's share price is NT$40.35. Center Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-0.10. Therefore, Center Laboratories's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-30), Center Laboratories's share price is NT$40.35. Center Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was NT$-0.22. Therefore, Center Laboratories's PE Ratio without NRI for today is At Loss.

During the past 13 years, Center Laboratories's highest PE Ratio without NRI was 1076.96. The lowest was 0.00. And the median was 56.24.


Center Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for Center Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Price-to-Owner-Earnings Chart

Center Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.85 31.06 - - -

Center Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 253.47

Competitive Comparison of Center Laboratories's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Price-to-Owner-Earnings falls into.


;
;

Center Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Center Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=40.35/0.14
=288.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Center Laboratories  (ROCO:4123) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Center Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.

Center Laboratories Headlines

No Headlines